From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.
about
Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communicationEmerging pharmacotherapies for neurodevelopmental disordersFinding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic targetThe role of mTOR signaling in Alzheimer diseaseActivation of a metabolic gene regulatory network downstream of mTOR complex 1Primary Cilia as a Possible Link between Left-Right Asymmetry and Neurodevelopmental Diseases.Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders.Both maternal and pup genotype influence ultrasonic vocalizations and early developmental milestones in tsc2 (+/-) mice.A pulse rapamycin therapy for infantile spasms and associated cognitive decline.The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease.Rapamycin for treating Tuberous sclerosis and Autism spectrum disordersThe interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.The small GTPase Rheb affects central brain neuronal morphology and memory formation in Drosophila.Genome-wide analysis of H4K5 acetylation associated with fear memory in miceToward fulfilling the promise of molecular medicine in fragile X syndromeSweet taste receptor signaling network: possible implication for cognitive functioning.Mutations causing syndromic autism define an axis of synaptic pathophysiology.Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND ChecklistRole for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neuronsEducation of a child neurologist: developmental neuroscience relevant to child neurology.Above genetics: lessons from cerebral development in autism.Mitochondrial deficiency: a double-edged sword for aging and neurodegeneration.Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiationEstradiol-induced object recognition memory consolidation is dependent on activation of mTOR signaling in the dorsal hippocampusHypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complexSex differences in cerebellar synaptic transmission and sex-specific responses to autism-linked Gabrb3 mutations in mice.Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures.Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment.Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.TOR on the brain.The genetics of child psychiatric disorders: focus on autism and Tourette syndrome.Behavioral profiles of mouse models for autism spectrum disorders.Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.Epilepsy in four genetically determined syndromes of intellectual disability.Molecular therapies for tuberous sclerosis and neurofibromatosis.Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.New models for considering the role of medication in the treatment and elucidation of the etiology of autism.Targeting the mTOR signaling network for Alzheimer's disease therapy.
P2860
Q21198697-95FB78B5-3F02-4AC2-B086-3CEB6AC4E1F3Q24619170-1A64099E-4B62-453C-B21F-8C893123D22CQ27024547-A3C97E08-0C2A-42B2-96BA-FD41621CDD51Q28256247-FA3DBE39-834B-43E3-B5C5-A525E00E94A8Q29615179-4418BF45-F2CD-4C80-9733-6E64AAA1DCEEQ30361244-79E7EF0C-DF3E-4072-8E1C-B2DCF5EC401FQ30399814-46DF5A66-4E1E-4F2D-B469-786332258096Q30432308-572FEA77-C416-4497-92DD-F3CBFFA28137Q30501073-826E37F0-0795-440C-8D4F-796CF4B6E8F9Q33914286-7F72A00E-F5F0-4187-9F76-4692AD818EBEQ34024856-3FA9109D-08DA-430F-A70C-15ED616D053AQ34261603-8C8A0020-DC3F-400B-AE73-9100D950273DQ34427606-EA991993-0712-4171-847D-AECE767A0766Q34910865-6ADA3219-777F-421F-A488-BAB867EBF03AQ34999452-7A775456-28CD-487A-B27B-E77D565E4F3CQ35012275-D66A16CC-4FD3-458F-9735-1CE73D54EF76Q35587150-8873039D-9DB8-4E75-A6BD-2BEB4E67082DQ35593184-E148963C-3BF0-4EFB-899E-7D8FB11F50D3Q35634446-43F606E7-F588-43EA-A9B7-7905D4EBA79CQ35789190-3AD1A70A-EDA6-42B7-A488-B391D24F10FDQ35902641-5AE6B80E-50DC-496A-BE1D-4DFF3508ADB1Q36464286-71835409-C2B0-4447-B298-3183CA0F363CQ36533150-53682690-C182-45CB-9BB6-31A69AC84563Q36626391-5C512261-C966-452B-8966-089F8D184BE5Q36731382-345E0B08-27BE-43CC-81A7-861E53D2934DQ36932106-8E510A06-F9D5-4E89-9BD8-C76E79595E60Q37068738-04732D29-F9D5-410B-9D87-842148CB8B9DQ37579637-95855866-B5F3-4BC9-9139-DB3AAF5E5B59Q37703975-CB65F52D-04C8-4801-8E5E-4DF31E17B2ABQ37774096-C0D2588A-C8F1-4447-8DE0-60867FFA3350Q37789848-1692C73B-E3ED-4D24-8F9B-7FBE4C648B89Q37801080-7C0A4C36-2D89-4384-98DC-BCFB14D86801Q37844007-E764EBAE-04AA-4BD0-A843-AEF143FB9F42Q37931887-1FEDDCFD-E388-4416-9597-4B59C436A3D6Q37964799-6CF8EA48-1850-4A43-91B9-74E5CFB2E20CQ38006431-BE189F50-C541-4B1C-97CB-D66668B2F236Q38027944-CC095F78-6BC1-4297-9649-EDAA27840F4AQ38028872-351D8BDB-5998-4700-A091-D37663DCD24CQ38044266-B1A474D8-360C-4DD6-A4E6-DF6CF9C534E0Q38121524-EE838479-F4F9-4E93-8FA0-91FFED176DC0
P2860
From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@ast
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@en
type
label
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@ast
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@en
prefLabel
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@ast
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@en
P2093
P2860
P1476
From mTOR to cognition: molecu ...... irments in tuberous sclerosis.
@en
P2093
D Ehninger
P J de Vries
P2860
P304
P356
10.1111/J.1365-2788.2009.01208.X
P577
2009-08-19T00:00:00Z